Valuation: BOIRON

Market Cap 458M 531M 431M 392M 736M 50.75B 749M 5.05B 1.97B 25.41B 1.99B 1.95B 84.45B P/E 2024
41x
P/E 2025 16.1x
Enterprise Value 411M 475M 386M 351M 660M 45.45B 670M 4.52B 1.77B 22.76B 1.78B 1.75B 75.63B EV / Sales 2024
0.85x
EV / Sales 2025 0.95x
Free-Float
19.96%
Yield 2024
4.48%
Yield 2025 4.46%
1 day-0.38%
Current month-4.01%
1 month-1.87%
3 months-5.40%
6 months-3.84%
Current year-13.20%
1 week 25.7
Extreme 25.7
26.7
1 month 25.7
Extreme 25.7
28
Current year 24.35
Extreme 24.35
30.95
1 year 20.9
Extreme 20.9
32.25
3 years 20.85
Extreme 20.85
56.5
5 years 20.85
Extreme 20.85
56.5
10 years 20.85
Extreme 20.85
92.91
Manager TitleAgeSince
Chief Executive Officer 57 01/01/2025
Chief Tech/Sci/R&D Officer - -
Chief Tech/Sci/R&D Officer - 01/01/2022
Director TitleAgeSince
Chairman 65 01/07/2011
Director/Board Member 54 10/03/2010
Director/Board Member 51 23/05/2013
Date Insider Type Main position Quantity % Market Cap.
29/10/23 Sell

Director

198,664 1.1323%
29/10/23 Sell

Director

462,964 2.6387%
29/10/23 Sell

Director

4,748 0.0271%
Change 5-day change 1-year change 3-year change Capi.($)
-0.38%0.00%+25.24%-48.43% 531M
-0.46%-1.89%-11.01%-6.99% 13.24B
-0.16%-2.40%-32.52%-57.64% 4.98B
-0.81%-3.56%+2.32%-3.16% 4.91B
+0.29%+0.12%+7.12%-28.17% 4.2B
-0.03%-2.74%-18.37%+0.58% 3.59B
+0.20%-2.29%-5.07%+13.86% 3.4B
-1.06%-6.37%-8.56%-9.04% 3.35B
+1.19%+0.94%-12.60%-15.53% 2.49B
0.00%+10.60%+3.45%-10.45% 1.81B
Average -0.12%-0.52%-5.00%-16.50% 4.25B
Weighted average by Cap. -0.23%-1.33%-9.17%-13.59%

Financials

2024 2025
Net sales 488M 565M 458M 417M 783M 53.98B 796M 5.37B 2.1B 27.03B 2.12B 2.07B 89.83B 501M 580M 471M 428M 805M 55.48B 818M 5.52B 2.16B 27.78B 2.18B 2.13B 92.32B
Net income 11.34M 13.12M 10.65M 9.69M 18.21M 1.26B 18.51M 125M 48.8M 628M 49.28M 48.21M 2.09B 32.64M 37.79M 30.67M 27.9M 52.45M 3.61B 53.31M 359M 141M 1.81B 142M 139M 6.01B
Net Debt -49.74M -57.59M -46.74M -42.51M -79.91M -5.51B -81.23M -548M -214M -2.76B -216M -212M -9.16B -47.86M -55.41M -44.97M -40.9M -76.89M -5.3B -78.16M -527M -206M -2.65B -208M -204M -8.82B
Logo BOIRON
Laboratoires BOIRON was founded in France almost a century ago, under the impetus of homeopathic doctors who wanted to benefit from the most reliable medicines possible. Homeopathic medicines have many advantages in that they can be prescribed and advised in first line whenever relevant, in both urban and hospital settings. All actions aim to contribute to major public health issues. Homeopathic medicines are obtained from substances called homeopathic strains, according to a manufacturing process described in the pharmacopoeia. These strains can be of plant, animal, mineral or chemical origin. There are two main families of homeopathic medicines: common name homeopathic medicines and brand name homeopathic medicines (specialties). BOIRON group centralizes its production and logistics in France. It also has 26 wholly-owned or leased distribution facilities in France and various offices in the countries where it has subsidiaries. Net sales are distributed geographically as follows: France (43.5%), Europe (24%), North America (27.5%) and other (5%).
Employees
2,499
Date Price Change Volume
17/08/26 26.30 -0.38% 1,004
14/08/26 €26.40 -0.38% 2,710
13/08/26 €26.50 0.00% 713
12/08/26 €26.50 +1.53% 772
11/08/26 €26.10 -0.76% 21,624

Annual profits - Rate of surprise